Skip Navigation

Rheumatology 2006 45(Supplement 3):iii1-iii2; doi:10.1093/rheumatology/kel279
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Distler, O.
Right arrow Articles by Müller-Ladner, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Distler, O.
Right arrow Articles by Müller-Ladner, U.
Related Collections
Right arrow Soft Tissue Rheumatism
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Novel aspects in the epidemiology, pathophysiology and treatment of connective tissue diseases

O. Distler and U. Müller-Ladner1

Department of Rheumatology, University Hospital Zurich, Switzerland and 1Department of Rheumatology and Clinical Immunology, University of Giessen and Marburg, Kerckhoff Clinic Bad Nauheim, Germany.

Correspondence to: O. Distler, MD, Department of Rheumatology, University Hospital Zurich, Gloriastr. 25, 8091 Zurich, Switzerland. E-mail: Oliver.Distler@usz.ch

The first 10% of the full text of this article appears below.

The past decade has been marked by rapid advances in molecular biology techniques, which are now routinely and commercially available for research groups around the world. Examples include the microarray technique and methods for gene silencing such as small interference RNA (siRNA) and cell transfection with anti-sense constructs. For research groups interested in the pathogenesis of certain diseases, these novel techniques allow a rapid high throughput screening for genes which are differentially expressed in health and disease, and might thus be of functional importance for disease development . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?